Author

S. B. Furgeson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:flow cytometry· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:clinical cohort / trial· 1 Assay:metabolomics· 1 Assay:proteomics· 1

Frequent Co-Authors

A. S. Li· 1 shared B. Y. Gitomer· 1 shared C. D. Bauer· 1 shared D. Floyd· 1 shared D. T. Nguyen· 1 shared E. K. Kleczko· 1 shared E. T. Clambey· 1 shared J. R. Colbert· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. S. Li

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

AKI and CKD Worsen Outcomes in Experimental Sepsis: Creating a Reverse-translational Model of Acute Peritoneal Infection and Recovery in an Immunocompromised Host.

D. Floyd, J. R. Colbert, S. B. Furgeson, J. R. Montford

This study shows that mice with acute kidney injury (AKI) or chronic kidney disease (CKD) have worse outcomes from sepsis compared to controls, with AKI causing more severe and earlier mortality.

bioRxiv · Mar 1, 2023 · PreprintImmunology

Immune Checkpoint Activity Regulates Polycystic Kidney Disease Progression

E. K. Kleczko, D. T. Nguyen, K. H. Marsh, C. D. Bauer, A. S. Li, S. B. Furgeson, B. Y. Gitomer, M. B. Chonchol, E. T. Clambey, K. A. Zimmerman, R. A. Nemenoff, K. Hopp

This study investigates immune checkpoint activity in ADPKD, finding that dual checkpoint inhibition improves disease outcomes in adult-onset models.

bioRxiv · Apr 24, 2022Immunology